Qbiotics, page-1155

HI Rajenp5,

I have just had a look at post shared by Avarice67 re current trails and end dates.

These are big trials so not sure if phase 3's would need to be big also.

Phase 3 wouldn't be cheap, US$300m

So close to US$1bn if they want to go all x 3 alone.

x 3 positive phase 2's would change the share price significantly, perhaps would need evaluate then based on price.

Would have to think x 3 phase 2 complete assets would be worth US $1.5-$2bn each?

There would be plenty of interest from other big pharmas to TO at US$6bn or alternativly partner or licence as a option also.